Yonhap Infomax News<p>Cheniere Energy, Novo Nordisk, and Welltower stocks recommended amid U.S. tariff policy uncertainty, with Cheniere seen as biggest beneficiary of potential trade deals.<br><a href="https://mastodon.social/tags/YonhapInfomax" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>YonhapInfomax</span></a> <a href="https://mastodon.social/tags/CheniereEnergy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CheniereEnergy</span></a> <a href="https://mastodon.social/tags/TariffPolicies" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>TariffPolicies</span></a> <a href="https://mastodon.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> <a href="https://mastodon.social/tags/Welltower" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Welltower</span></a> <a href="https://mastodon.social/tags/TradeDisputes" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>TradeDisputes</span></a> <a href="https://mastodon.social/tags/Economics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Economics</span></a> <a href="https://mastodon.social/tags/FinancialMarkets" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>FinancialMarkets</span></a> <a href="https://mastodon.social/tags/Banking" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Banking</span></a> <a href="https://mastodon.social/tags/Securities" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Securities</span></a> <a href="https://mastodon.social/tags/Bonds" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Bonds</span></a> <a href="https://mastodon.social/tags/StockMarket" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>StockMarket</span></a> <br><a href="https://en.infomaxai.com/news/articleView.html?idxno=58710" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">en.infomaxai.com/news/articleV</span><span class="invisible">iew.html?idxno=58710</span></a></p>
Recent searches
No recent searches
Search options
Not available on me.dm.
me.dm is part of the decentralized social network powered by Mastodon.
Ideas and information to deepen your understanding of the world. Run by the folks at Medium.
Administered by:
Server stats:
1.6Kactive users
Learn more
me.dm: About · Profiles directory · Privacy policy
Mastodon: About · Get the app · Keyboard shortcuts · View source code · v4.2.18
#NovoNordisk
1 post · 1 participant · 0 posts today
Mediapart<p>La cynique alliance de la malbouffe et du grand laboratoire prétendant lutter contre l’obésité </p><p><a href="https://mediapart.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> commercialise des médicaments amaigrissants et, officiellement, la fondation du laboratoire se mobilise pour prévenir l’obésité. La réalité est tout autre. Son vice-président a par exemple été payé par Ferrero, Nestlé, McDonald’s et McCain. </p><p>› <a href="https://www.mediapart.fr/journal/france/050425/la-cynique-alliance-de-la-malbouffe-et-du-grand-laboratoire-pretendant-lutter-contre-l-obesite?at_medium=rs-cm&at_campaign=mastodon&at_account=mediapart" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">mediapart.fr/journal/france/05</span><span class="invisible">0425/la-cynique-alliance-de-la-malbouffe-et-du-grand-laboratoire-pretendant-lutter-contre-l-obesite?at_medium=rs-cm&at_campaign=mastodon&at_account=mediapart</span></a></p>
Aboumael ⏚🔻🇺🇦 🇵🇸<p>[Médiapart] - La cynique alliance de la malbouffe et du grand laboratoire prétendant lutter contre l’obésité</p><p><a href="https://piaille.fr/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> commercialise des médicaments amaigrissants et, officiellement, la fondation du laboratoire se mobilise pour prévenir l’obésité. La réalité est tout autre. Son vice-président a par exemple été payé par <a href="https://piaille.fr/tags/Ferrero" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Ferrero</span></a>, <a href="https://piaille.fr/tags/Nestl%C3%A9" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Nestlé</span></a>, <a href="https://piaille.fr/tags/McDonald" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>McDonald</span></a>’s et <a href="https://piaille.fr/tags/McCain" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>McCain</span></a>.</p><p><a href="https://www.mediapart.fr/journal/france/050425/la-cynique-alliance-de-la-malbouffe-et-du-grand-laboratoire-pretendant-lutter-contre-l-obesite" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">mediapart.fr/journal/france/05</span><span class="invisible">0425/la-cynique-alliance-de-la-malbouffe-et-du-grand-laboratoire-pretendant-lutter-contre-l-obesite</span></a></p><p><a href="https://piaille.fr/tags/ob%C3%A9sit%C3%A9" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>obésité</span></a> <a href="https://piaille.fr/tags/Malbouffe" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Malbouffe</span></a> <br><a href="https://piaille.fr/tags/Sant%C3%A9" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Santé</span></a> <a href="https://piaille.fr/tags/Health" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Health</span></a> <a href="https://piaille.fr/tags/RevueDePresse" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>RevueDePresse</span></a> <a href="https://piaille.fr/tags/Press" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Press</span></a></p>
Europe Says<p><a href="https://www.europesays.com/1939039/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">europesays.com/1939039/</span><span class="invisible"></span></a> SAP has just become Europe’s most valuable company, dethroning Novo Nordisk <a href="https://pubeurope.com/tags/europe" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>europe</span></a> <a href="https://pubeurope.com/tags/MarketCapitalisation" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>MarketCapitalisation</span></a> <a href="https://pubeurope.com/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> <a href="https://pubeurope.com/tags/SAP" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>SAP</span></a> <a href="https://pubeurope.com/tags/Shares" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Shares</span></a> <a href="https://pubeurope.com/tags/StockExchange" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>StockExchange</span></a></p>
Yonhap Infomax News<p>Novo Nordisk's ADR rises 1.04% to $80.98 following UBS's positive assessment and buy recommendation, despite overall market decline, as competition in obesity treatment market intensifies.<br><a href="https://mastodon.social/tags/YonhapInfomax" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>YonhapInfomax</span></a> <a href="https://mastodon.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> <a href="https://mastodon.social/tags/ADR" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ADR</span></a> <a href="https://mastodon.social/tags/UBS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UBS</span></a> <a href="https://mastodon.social/tags/ObesityTreatment" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ObesityTreatment</span></a> <a href="https://mastodon.social/tags/GLP1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GLP1</span></a> <a href="https://mastodon.social/tags/Economics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Economics</span></a> <a href="https://mastodon.social/tags/FinancialMarkets" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>FinancialMarkets</span></a> <a href="https://mastodon.social/tags/Banking" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Banking</span></a> <a href="https://mastodon.social/tags/Securities" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Securities</span></a> <a href="https://mastodon.social/tags/Bonds" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Bonds</span></a> <a href="https://mastodon.social/tags/StockMarket" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>StockMarket</span></a> <br><a href="https://en.infomaxai.com/news/articleView.html?idxno=54698" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">en.infomaxai.com/news/articleV</span><span class="invisible">iew.html?idxno=54698</span></a></p>
Yonhap Infomax News<p>Novo Nordisk's disappointing clinical trial results for advanced obesity treatment lead to sharp declines in Wegovy-related stocks, impacting both Novo Nordisk and competitor Eli Lilly<br><a href="https://mastodon.social/tags/YonhapInfomax" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>YonhapInfomax</span></a> <a href="https://mastodon.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> <a href="https://mastodon.social/tags/ClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrial</span></a> <a href="https://mastodon.social/tags/Wegovy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Wegovy</span></a> <a href="https://mastodon.social/tags/ObesityTreatment" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ObesityTreatment</span></a> <a href="https://mastodon.social/tags/EliLilly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EliLilly</span></a> <a href="https://mastodon.social/tags/Economics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Economics</span></a> <a href="https://mastodon.social/tags/FinancialMarkets" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>FinancialMarkets</span></a> <a href="https://mastodon.social/tags/Banking" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Banking</span></a> <a href="https://mastodon.social/tags/Securities" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Securities</span></a> <a href="https://mastodon.social/tags/Bonds" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Bonds</span></a> <a href="https://mastodon.social/tags/StockMarket" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>StockMarket</span></a> <br><a href="https://en.infomaxai.com/news/articleView.html?idxno=53688" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">en.infomaxai.com/news/articleV</span><span class="invisible">iew.html?idxno=53688</span></a></p>
Teslagauss1884<p><span class="h-card" translate="no"><a href="https://mediapart.social/@mediapart" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>mediapart</span></a></span> <br>Aussi ne prenez pas d ozempic a moins d'avoir des problèmes extrêmement particulier. Ce médicament fout en l'air les centres de la récompense et perturbent les centres de la joie . Et ça peut provoquer des gastroparesie. Soit une immobilisation du système digestif<br><a href="https://rivals.space/tags/ozempic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ozempic</span></a> <a href="https://rivals.space/tags/novonordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>novonordisk</span></a></p>
JIBIN<p>🌍💊 Novo Nordisk's weight-loss drug Wegovy sees a massive 57% sales increase, doubling patient numbers to 2.2 million worldwide! The company anticipates up to 24% growth in 2025. <br><a href="https://www.pharmacy.biz/news/novo-nordisk-sees-strong-surge-in-wegovy-sales/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">pharmacy.biz/news/novo-nordisk</span><span class="invisible">-sees-strong-surge-in-wegovy-sales/</span></a></p><p>More details here: pharmacy.biz 🏥 <a href="https://mastodon.social/tags/Healthcare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Healthcare</span></a> <a href="https://mastodon.social/tags/ObesityTreatment" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ObesityTreatment</span></a> <a href="https://mastodon.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a></p>
Ben Royce 🇺🇦<p><span class="h-card" translate="no"><a href="https://sfba.social/@pmonks" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>pmonks</span></a></span> <span class="h-card" translate="no"><a href="https://m.ai6yr.org/@ai6yr" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>ai6yr</span></a></span> </p><p><a href="https://mastodon.social/tags/Denmark" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Denmark</span></a> <a href="https://mastodon.social/tags/Trump" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Trump</span></a> <a href="https://mastodon.social/tags/Ozempic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Ozempic</span></a> <a href="https://mastodon.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a></p>
Glyn Moody<p>The King of <a href="https://mastodon.social/tags/Ozempic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Ozempic</span></a> Is Scared as Hell - <a href="https://www.wired.com/story/novo-nordisk-king-of-ozempic-scared-as-hell/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">wired.com/story/novo-nordisk-k</span><span class="invisible">ing-of-ozempic-scared-as-hell/</span></a> "Now that <a href="https://mastodon.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?"</p>
J. Steven York RESISTS<p>Update on the insulin situation. I had a new prescription for a different insulin Monday morning. I was able to pick it up a couple hours later and immediately get my daily shot, about ten hours late, which isn't critical for me. No problems so far, and I like the functionality of the injector pen much better than the old Novo Nordisk one, which was cranky and sometimes difficult to inject, even for a guy with big, fairly strong, hands.</p><p><a href="https://mastodon.social/tags/usHealthCare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>usHealthCare</span></a> <a href="https://mastodon.social/tags/novoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>novoNordisk</span></a> <a href="https://mastodon.social/tags/insulin" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>insulin</span></a> <a href="https://mastodon.social/tags/diabetes" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>diabetes</span></a></p>
J. Steven York RESISTS<p>And if you're considering taking Ozempic for weight loss, let me say that while the side-effects are probably worth it if you're a diabetic like me, I can't imagine doing it just hoping to lose a few pounds. There have to be easier ways than all the time I spend in the bathroom, imposed dietary limitations, and dealing with other digestive impact. <br><a href="https://mastodon.social/tags/usHealthCare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>usHealthCare</span></a> <a href="https://mastodon.social/tags/pharma" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>pharma</span></a> <a href="https://mastodon.social/tags/novoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>novoNordisk</span></a> <a href="https://mastodon.social/tags/insulin" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>insulin</span></a> <a href="https://mastodon.social/tags/diabetes" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>diabetes</span></a> <a href="https://mastodon.social/tags/ozempic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ozempic</span></a></p>
☮ ♥ ♬ 🧑💻<p>“A fourth factor in <a href="https://ioc.exchange/tags/Nordic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Nordic</span></a> outperformance is patient shareholders. According to <a href="https://ioc.exchange/tags/McKinsey" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>McKinsey</span></a>, a consultancy, four-fifths of large Nordic companies have long-term ownership, compared with three-fifths in Europe and only a fifth in America. Business dynasties play a prominent role in the region. <a href="https://ioc.exchange/tags/Maersk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Maersk</span></a> and <a href="https://ioc.exchange/tags/Lego" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Lego</span></a> are still controlled, respectively, by the founding Moller and Kristiansen families, though both firms are run day-to-day by outsiders. In <a href="https://ioc.exchange/tags/Sweden" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Sweden</span></a> the Wallenbergs, whose fortune originated in banking, own large stakes in various companies, including <a href="https://ioc.exchange/tags/AtlasCopco" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AtlasCopco</span></a> and <a href="https://ioc.exchange/tags/Ericsson" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Ericsson</span></a>. Other big Nordic firms, including <a href="https://ioc.exchange/tags/Carlsberg" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Carlsberg</span></a> and <a href="https://ioc.exchange/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a>, are controlled by non-profit foundations.</p><p>Such arrangements have prevented foreign firms from snapping up Nordic companies, giving them more time to grow. They have also made it easier for companies to invest in their long-term success. McKinsey reckons that four-fifths of listed Nordic companies spend more on <a href="https://ioc.exchange/tags/research" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>research</span></a> and <a href="https://ioc.exchange/tags/development" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>development</span></a> than their rivals do elsewhere in the West. Lars Fruergaard Jorgensen, Novo Nordisk’s boss, has said that his main focus is how the company will look in ten to 20 years”</p><p><a href="https://ioc.exchange/tags/business" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>business</span></a> / <a href="https://ioc.exchange/tags/stability" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>stability</span></a> / <a href="https://ioc.exchange/tags/technology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>technology</span></a> <<a href="http://active.econweb.p.aws.economist.com/business/2024/12/30/why-are-nordic-companies-so-successful" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">http://</span><span class="ellipsis">active.econweb.p.aws.economist</span><span class="invisible">.com/business/2024/12/30/why-are-nordic-companies-so-successful</span></a>></p>
nemo™ 🇺🇦<p><a href="https://mas.to/tags/ironie" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ironie</span></a>, Wenn ich er wäre, würde ich meine Aussagen mit bedacht treffen. Wenn sie das Ozempic zurückziehen, haben die USA ein dickes Problem. <a href="https://mas.to/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a></p>
Juha Haataja<p>Pörssikurssi laihtui?</p><p>"Testissä olleen uuden laihdutuslääkkeen Cagriseman odotettiin pudottavan tutkimuksessa mukana olleiden painoa 25 prosenttia tutkimuksen aikana. Heidän painonsa kuitenkin putosi keskimäärin vain alle 23 prosenttia. ... Pörssikurssit reagoivat tulokseen lähtemällä parinkymmenen prosentin syöksyyn."</p><p><a href="https://mastodon.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> </p><p><a href="https://yle.fi/a/74-20132987" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="">yle.fi/a/74-20132987</span><span class="invisible"></span></a></p>
Benjamin Carr, Ph.D. 👨🏻💻🧬<p><a href="https://hachyderm.io/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> sells hit <a href="https://hachyderm.io/tags/weight" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>weight</span></a>-loss drug in <a href="https://hachyderm.io/tags/China" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>China</span></a>—at fraction of US price<br>As US struggles to afford <a href="https://hachyderm.io/tags/GLP1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GLP1</span></a> <a href="https://hachyderm.io/tags/drugs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>drugs</span></a>, the rest of the world sees much lower prices.<br><a href="https://arstechnica.com/health/2024/11/novo-nordisk-sells-hit-weight-loss-drug-in-china-at-fraction-of-us-price/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">arstechnica.com/health/2024/11</span><span class="invisible">/novo-nordisk-sells-hit-weight-loss-drug-in-china-at-fraction-of-us-price/</span></a></p>
Global News National<p>Wegovy approved in Canada to combat risk of non fatal-heart attack<br>Health Canada has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults.<br><a href="https://mastodon.hongkongers.net/tags/globalnews" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>globalnews</span></a> <a href="https://mastodon.hongkongers.net/tags/Canada" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Canada</span></a> <a href="https://mastodon.hongkongers.net/tags/Health" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Health</span></a> <a href="https://mastodon.hongkongers.net/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> <a href="https://mastodon.hongkongers.net/tags/Wegovy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Wegovy</span></a> <br><a href="https://globalnews.ca/news/10890649/wegovy-canada-approval-non-fatal-heart-attack/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">globalnews.ca/news/10890649/we</span><span class="invisible">govy-canada-approval-non-fatal-heart-attack/</span></a></p>
The Japan Times<p>Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted strong third-quarter earnings despite being held back by production constraints. <a href="https://www.japantimes.co.jp/business/2024/11/06/obesity-drugmaker-novo-nordisk-profit/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">japantimes.co.jp/business/2024</span><span class="invisible">/11/06/obesity-drugmaker-novo-nordisk-profit/</span></a> <a href="https://mastodon.social/tags/business" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>business</span></a> <a href="https://mastodon.social/tags/novonordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>novonordisk</span></a> <a href="https://mastodon.social/tags/ozempic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ozempic</span></a> <a href="https://mastodon.social/tags/wegovy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>wegovy</span></a></p>
gtbarry<p>With Novo Nordisk success, is there a "Nokia risk" for Denmark?</p><p>Novo Nordisk's success with Wegovy and Ozempic has led to huge profits: its current market capitalization is larger than Denmark's entire GDP. </p><p>"The risk here is that this is one sector. There are dangers that come with having one sector be so dependent for so much growth."</p><p><a href="https://mastodon.social/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> <a href="https://mastodon.social/tags/Wegovy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Wegovy</span></a> <a href="https://mastodon.social/tags/Ozempic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Ozempic</span></a> <a href="https://mastodon.social/tags/Denmark" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Denmark</span></a> <a href="https://mastodon.social/tags/Nokia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Nokia</span></a> <a href="https://mastodon.social/tags/Finland" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Finland</span></a> <a href="https://mastodon.social/tags/pharmaceuticals" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>pharmaceuticals</span></a> <a href="https://mastodon.social/tags/Biotech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Biotech</span></a> <a href="https://mastodon.social/tags/GLP1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GLP1</span></a> <a href="https://mastodon.social/tags/economics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>economics</span></a> <a href="https://mastodon.social/tags/GDP" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GDP</span></a> <a href="https://mastodon.social/tags/business" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>business</span></a></p><p><a href="https://www.cbsnews.com/news/with-novo-nordisk-success-is-there-a-nokia-risk-for-denmark-60-minutes/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">cbsnews.com/news/with-novo-nor</span><span class="invisible">disk-success-is-there-a-nokia-risk-for-denmark-60-minutes/</span></a></p>
Europe Says<p><a href="https://www.europesays.com/1585063/" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://www.</span><span class="">europesays.com/1585063/</span><span class="invisible"></span></a> Danish town where Ozempic is made has highest rates of overweight children in Denmark <a href="https://pubeurope.com/tags/AndWellness" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AndWellness</span></a> <a href="https://pubeurope.com/tags/Danmark" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Danmark</span></a> <a href="https://pubeurope.com/tags/denmark" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>denmark</span></a> <a href="https://pubeurope.com/tags/Editor" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Editor</span></a>'sPicks <a href="https://pubeurope.com/tags/Featured" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Featured</span></a> <a href="https://pubeurope.com/tags/fitness" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>fitness</span></a> <a href="https://pubeurope.com/tags/Fortune500Europe" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Fortune500Europe</span></a> <a href="https://pubeurope.com/tags/health" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>health</span></a> <a href="https://pubeurope.com/tags/NovoNordisk" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NovoNordisk</span></a> <a href="https://pubeurope.com/tags/PersonalHealth" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>PersonalHealth</span></a> <a href="https://pubeurope.com/tags/PharmaceuticalIndustry" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>PharmaceuticalIndustry</span></a> <a href="https://pubeurope.com/tags/retail" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>retail</span></a> <a href="https://pubeurope.com/tags/WeightLossAndDietControlIndustry" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>WeightLossAndDietControlIndustry</span></a></p>
ExploreLive feeds
Login to follow profiles or hashtags, favorite, share and reply to posts. You can also interact from your account on a different server.
LoginDrag & drop to upload